560.73
9.91 (1.80%)
| Penutupan Terdahulu | 550.82 |
| Buka | 547.63 |
| Jumlah Dagangan | 882,409 |
| Purata Dagangan (3B) | 577,609 |
| Modal Pasaran | 44,232,065,024 |
| Harga / Pendapatan (P/E TTM) | 41.32 |
| Harga / Pendapatan (P/E Ke hadapan) | 39.22 |
| Harga / Jualan (P/S) | 10.49 |
| Harga / Buku (P/B) | 29.35 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Aug 2026 |
| Margin Keuntungan | 22.76% |
| Margin Operasi (TTM) | 31.70% |
| EPS Cair (TTM) | 10.82 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 3.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 73.16% |
| Nisbah Semasa (MRQ) | 1.16 |
| Aliran Tunai Operasi (OCF TTM) | 968.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 761.15 M |
| Pulangan Atas Aset (ROA TTM) | 22.98% |
| Pulangan Atas Ekuiti (ROE TTM) | 59.33% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | IDEXX Laboratories, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.88 |
|
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.67% |
| % Dimiliki oleh Institusi | 97.51% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |